October 5 (SeeNews) - Bulgarian pharmaceuticals producer Sopharma [BUL:SFA] said on Wednesday its sales plunged by 36% year-on-year in September, reflecting weak domestic sales and exports.
The company registered in September a 54% annual drop in domestic sales while exports declined by 23%, it said in a stock exchange filing.
In the first nine months of 2022, Sopharma's sales rose by 20% in annual terms, including growth of 17% in domestic sales and a 23% increase in exports.
By 1351 CEST on Wednesday, shares in Sopharma traded flat at 4.50 levs on the Bulgarian Stock Exchange.
(1 euro = 1.95583 levs)